These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 25063808)

  • 21. Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways.
    Yecies JL; Zhang HH; Menon S; Liu S; Yecies D; Lipovsky AI; Gorgun C; Kwiatkowski DJ; Hotamisligil GS; Lee CH; Manning BD
    Cell Metab; 2011 Jul; 14(1):21-32. PubMed ID: 21723501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic mTOR-AKT2-Insig2 signaling pathway contributes to the improvement of hepatic steatosis after Roux-en-Y Gastric Bypass in mice.
    Pan Q; Qin T; Gao Y; Li S; Li D; Peng M; Zhai H; Xu G
    Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):525-534. PubMed ID: 30562559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Akt-independent regulation of hepatic lipogenesis by mammalian target of rapamycin (mTOR) complex 2.
    Yuan M; Pino E; Wu L; Kacergis M; Soukas AA
    J Biol Chem; 2012 Aug; 287(35):29579-88. PubMed ID: 22773877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic signaling by the mechanistic target of rapamycin complex 2 (mTORC2).
    Lamming DW; Demirkan G; Boylan JM; Mihaylova MM; Peng T; Ferreira J; Neretti N; Salomon A; Sabatini DM; Gruppuso PA
    FASEB J; 2014 Jan; 28(1):300-15. PubMed ID: 24072782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CLOCK/BMAL1 regulates circadian change of mouse hepatic insulin sensitivity by SIRT1.
    Zhou B; Zhang Y; Zhang F; Xia Y; Liu J; Huang R; Wang Y; Hu Y; Wu J; Dai C; Wang H; Tu Y; Peng X; Wang Y; Zhai Q
    Hepatology; 2014 Jun; 59(6):2196-206. PubMed ID: 24442997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amino Acids Attenuate Insulin Action on Gluconeogenesis and Promote Fatty Acid Biosynthesis via mTORC1 Signaling Pathway in trout Hepatocytes.
    Dai W; Panserat S; Plagnes-Juan E; Seiliez I; Skiba-Cassy S
    Cell Physiol Biochem; 2015; 36(3):1084-100. PubMed ID: 26112996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The GATOR2-mTORC2 axis mediates Sestrin2-induced AKT Ser/Thr kinase activation.
    Kowalsky AH; Namkoong S; Mettetal E; Park HW; Kazyken D; Fingar DC; Lee JH
    J Biol Chem; 2020 Feb; 295(7):1769-1780. PubMed ID: 31915252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Regulation of Lipid Deposition by Insulin in Goose Liver Cells Is Mediated by the PI3K-AKT-mTOR Signaling Pathway.
    Han C; Wei S; He F; Liu D; Wan H; Liu H; Li L; Xu H; Du X; Xu F
    PLoS One; 2015; 10(5):e0098759. PubMed ID: 25945932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elovl5 regulates the mTORC2-Akt-FOXO1 pathway by controlling hepatic cis-vaccenic acid synthesis in diet-induced obese mice.
    Tripathy S; Jump DB
    J Lipid Res; 2013 Jan; 54(1):71-84. PubMed ID: 23099444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic insulin resistance in ob/ob mice involves increases in ceramide, aPKC activity, and selective impairment of Akt-dependent FoxO1 phosphorylation.
    Sajan MP; Ivey RA; Lee MC; Farese RV
    J Lipid Res; 2015 Jan; 56(1):70-80. PubMed ID: 25395359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resveratrol Induces the Fasting State and Alters Circadian Metabolism in Hepatocytes.
    Chatam O; Chapnik N; Froy O
    Plant Foods Hum Nutr; 2022 Mar; 77(1):128-134. PubMed ID: 35178649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postprandial hepatic lipid metabolism requires signaling through Akt2 independent of the transcription factors FoxA2, FoxO1, and SREBP1c.
    Wan M; Leavens KF; Saleh D; Easton RM; Guertin DA; Peterson TR; Kaestner KH; Sabatini DM; Birnbaum MJ
    Cell Metab; 2011 Oct; 14(4):516-27. PubMed ID: 21982711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic Profile and Lipid Metabolism Phenotype in Mice with Conditional Deletion of Hepatic BMAL1.
    Gu W; Li T; Huang Y; Wang R; Zhang L; Chen R; Li R; Liu C
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dyrk1b promotes hepatic lipogenesis by bypassing canonical insulin signaling and directly activating mTORC2 in mice.
    Bhat N; Narayanan A; Fathzadeh M; Kahn M; Zhang D; Goedeke L; Neogi A; Cardone RL; Kibbey RG; Fernandez-Hernando C; Ginsberg HN; Jain D; Shulman GI; Mani A
    J Clin Invest; 2022 Feb; 132(3):. PubMed ID: 34855620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteome and Phosphoproteome Analysis of Brown Adipocytes Reveals That RICTOR Loss Dampens Global Insulin/AKT Signaling.
    Entwisle SW; Martinez Calejman C; Valente AS; Lawrence RT; Hung CM; Guertin DA; Villén J
    Mol Cell Proteomics; 2020 Jul; 19(7):1104-1119. PubMed ID: 32234964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic CREBZF couples insulin to lipogenesis by inhibiting insig activity and contributes to hepatic steatosis in diet-induced insulin-resistant mice.
    Zhang F; Hu Z; Li G; Huo S; Ma F; Cui A; Xue Y; Han Y; Gong Q; Gao J; Bian H; Meng Z; Wu H; Long G; Tan Y; Zhang Y; Lin X; Gao X; Xu A; Li Y
    Hepatology; 2018 Oct; 68(4):1361-1375. PubMed ID: 29637572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression.
    Zhang W; Patil S; Chauhan B; Guo S; Powell DR; Le J; Klotsas A; Matika R; Xiao X; Franks R; Heidenreich KA; Sajan MP; Farese RV; Stolz DB; Tso P; Koo SH; Montminy M; Unterman TG
    J Biol Chem; 2006 Apr; 281(15):10105-17. PubMed ID: 16492665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resveratrol Maintains Lipid Metabolism Homeostasis via One of the Mechanisms Associated with the Key Circadian Regulator Bmal1.
    Li J; Wei L; Zhao C; Li J; Liu Z; Zhang M; Wang Y
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31408938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RBM45 reprograms lipid metabolism promoting hepatocellular carcinoma via Rictor and ACSL1/ACSL4.
    Wang C; Chen Z; Yi Y; Ding Y; Xu F; Kang H; Lin K; Shu X; Zhong Z; Zhang Z; Liu J; Xu Z; Liu L; He X; Chang Y; Zhao Q
    Oncogene; 2024 Jan; 43(5):328-340. PubMed ID: 38040804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenesis of selective insulin resistance in isolated hepatocytes.
    Cook JR; Langlet F; Kido Y; Accili D
    J Biol Chem; 2015 May; 290(22):13972-80. PubMed ID: 25873396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.